Insider · CIK 0001279901

CARROLL J MARTIN

Reports to the SEC for 8 companies · ANN ARBOR, MI

sec.gov

Transactions

Companies

Filings

CIK

0001279901

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−178K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.5K sh	—	—	0
2026-05-28	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+79.9K sh	—	—	177,523
2025-05-29	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+33K sh	—	—	97,650
2025-05-29	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2024-12-18	Catalent, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−32.7K sh	—	—	0
2024-10-30	Catalent, Inc.A Award	Director	AAward	+4,663 sh	—	—	32,734
2024-05-23	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+23K sh	—	—	64,650
2024-05-23	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+32.5K sh	—	—	32,500
2023-10-27	Catalent, Inc.A Award	Director	AAward	+6,993 sh	—	—	28,071
2023-07-01	Catalent, Inc.A Award	Director	AAward	+555 sh	—	—	21,078
2023-06-15	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+5,150 sh	—	—	41,650
2023-06-15	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2023-05-11	ESPREsperion Therapeutics, Inc.P Purchase	Director	PPurchase	+23.1K sh	$1.57	+$36.3K	36,500
2023-05-10	ESPREsperion Therapeutics, Inc.P Purchase	Director	PPurchase	+8,409 sh	$1.49	+$12.5K	13,409
2022-10-27	Catalent, Inc.A Award	Director	AAward	+4,149 sh	—	—	20,523
2022-06-02	ESPREsperion Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$5.64	+$28.2K	5,000
2022-06-01	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-11-29	Catalent, Inc.J Other	Director	JOther	+3,136 sh	$134.12	+$421K	11,663
2021-11-29	Catalent, Inc.J Other	Director	JOther	−3,136 sh	$134.12	−$421K	0
2021-11-29	Catalent, Inc.G Gift	Director	GGift	+3,136 sh	—	—	3,136
2021-11-29	Catalent, Inc.G Gift	Director	GGift	−3,136 sh	—	—	16,374
2021-10-28	Catalent, Inc.A Award	Director	AAward	+1,402 sh	—	—	19,510
2021-08-10	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+96.9K sh	—	—	106,864
2021-08-10	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−96.9K sh	—	—	0
2021-07-01	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+99.2K sh	—	—	99,174
2021-03-12	Keenova Therapeutics plcS Sale	Director	SSale	−10.7K sh	$0.40	−$4,274.267	0
2021-03-12	Keenova Therapeutics plcS Sale	Director	SSale	−31.4K sh	$0.40	−$12.6K	0
2020-10-29	Catalent, Inc.A Award	Director	AAward	+2,125 sh	—	—	18,108
2020-08-27	Catalent, Inc.A Award	Director	AAward	+661 sh	—	—	15,983
2020-06-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+96.9K sh	—	—	96,864
2020-05-13	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−8,729 sh	$2.96	−$25.8K	10,667
2020-05-12	Catalent, Inc.G Gift	Director	GGift	+3,600 sh	—	—	3,600
2020-05-12	Catalent, Inc.G Gift	Director	GGift	−3,600 sh	—	—	15,322
2020-05-12	Catalent, Inc.J Other	Director	JOther	+3,600 sh	$72.29	+$260K	8,527
2020-05-12	Catalent, Inc.J Other	Director	JOther	−3,600 sh	$72.29	−$260K	0
2019-08-22	Catalent, Inc.A Award	Director	AAward	+3,167 sh	—	—	18,922
2019-07-15	Catalent, Inc.J Other	Director	JOther	−4,927 sh	$53.24	−$262K	0
2019-07-15	Catalent, Inc.J Other	Director	JOther	+4,927 sh	$53.24	+$262K	4,927
2019-07-15	Catalent, Inc.G Gift	Director	GGift	−4,927 sh	—	—	15,755
2019-07-15	Catalent, Inc.G Gift	Director	GGift	+4,927 sh	—	—	4,927
2019-06-20	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2019-05-30	Keenova Therapeutics plcG Gift	Director	GGift	−10.6K sh	—	—	19,396
2019-05-30	Keenova Therapeutics plcG Gift	Director	GGift	+10.6K sh	—	—	10,551
2019-05-30	Keenova Therapeutics plcJ Other	Director	JOther	−10.6K sh	$9.19	−$97K	0
2019-05-30	Keenova Therapeutics plcJ Other	Director	JOther	+10.6K sh	$9.19	+$97K	31,398
2019-05-15	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−8,527 sh	$15.21	−$130K	10,911
2019-05-15	Keenova Therapeutics plcA Award	Director	AAward	+19.4K sh	—	—	30,307

Recent filings

Accepted (ET)
Jul 134
CARROLL J MARTIN0001628280-26-048012
SEC(opens sec.gov)
Jun 14
CARROLL J MARTIN0001628280-26-039520
SEC(opens sec.gov)
Jun 24
CARROLL J MARTIN0001628280-25-028830
SEC(opens sec.gov)
Dec 184
CARROLL J MARTIN0000950170-24-137708
SEC(opens sec.gov)
Nov 14
CARROLL J MARTIN0001596783-24-000101
SEC(opens sec.gov)
May 244
CARROLL J MARTIN0001628280-24-025223
SEC(opens sec.gov)
Oct 314
CARROLL J MARTIN0001596783-23-000159
SEC(opens sec.gov)
Jul 74
CARROLL J MARTIN0001596783-23-000044
SEC(opens sec.gov)
Jun 164
CARROLL J MARTIN0001628280-23-022457
SEC(opens sec.gov)
May 114
CARROLL J MARTIN0001628280-23-017563
SEC(opens sec.gov)
Oct 314
CARROLL J MARTIN0001596783-22-000163
SEC(opens sec.gov)
Jun 34
CARROLL J MARTIN0001628280-22-016165
SEC(opens sec.gov)
Jun 14
CARROLL J MARTIN0001628280-22-015913
SEC(opens sec.gov)

Companies

Address

C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150

ANN ARBOR, MI, 48108